4//SEC Filing
Hammill Kevin Austin 4
Accession 0001209191-18-028461
CIK 0001441693other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 7:50 PM ET
Size
5.7 KB
Accession
0001209191-18-028461
Insider Transaction Report
Form 4
Hammill Kevin Austin
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-05-07+400,000→ 400,000 totalExercise: $1.73Exp: 2028-05-03→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting twelve months after the Vesting Commencement Date of May 3, 2018, and the remaining shares vesting in equal monthly installments over the remaining 36 months at the rate of 1/48th, subject to Optionee's continued employment.
Documents
Issuer
MARRONE BIO INNOVATIONS INC
CIK 0001441693
Entity typeother
Related Parties
1- filerCIK 0001739741
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 7:50 PM ET
- Size
- 5.7 KB